Arcturus Therapeutics Holdings (ARCT) Assets Average (2019 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 8 years of Assets Average data on file, last reported at $258.3 million in Q1 2026.

• Quarterly Assets Average fell 23.57% year-over-year to $258.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.3 million (down 23.57% YoY) and the FY2025 annual result came in at $307.6 million, down 20.46% from the prior year.
• Assets Average fell to $258.3 million in Q1 2026, from $276.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $460.6 million in Q1 2023 to a low of $258.3 million in Q1 2026.
• A 5-year average of $367.5 million and a median of $367.4 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average dropped 28.61% — and 2023, when it surged 40.86%.
• Tracing ARCT's Assets Average over 5 years: stood at $372.0 million in 2022, then gained by 19.23% to $443.5 million in 2023, then retreated by 19.43% to $357.4 million in 2024, then dropped by 22.56% to $276.7 million in 2025, then fell by 6.67% to $258.3 million in 2026.
• The last three Assets Average figures came in at $258.3 million (Q1 2026), $276.7 million (Q4 2025), and $295.8 million (Q3 2025), per Business Quant data.